Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

High yield of culture-based diagnosis in a TB-endemic setting

Authors: Anne-Marie Demers, Suzanne Verver, Andrew Boulle, Robin Warren, Paul van Helden, Marcel A Behr, David Coetzee

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

In most of the world, microbiologic diagnosis of tuberculosis (TB) is limited to microscopy. Recent guidelines recommend culture-based diagnosis where feasible.

Methods

In order to evaluate the relative and absolute incremental diagnostic yield of culture-based diagnosis in a high-incidence community in Cape Town, South Africa, subjects evaluated for suspected TB had their samples processed for microscopy and culture over a 21 month period.

Results

For 2537 suspect episodes with 2 smears and 2 cultures done, 20.0% (508) had at least one positive smear and 29.9% (760) had at least one positive culture. One culture yielded 1.8 times more cases as 1 smear (relative yield), or an increase of 12.0% (absolute yield). Based on the latter value, the number of cultures needed to diagnose (NND) one extra case of TB was 8, compared to 19 if second specimens were submitted for microscopy.

Conclusion

In a high-burden setting, the introduction of culture can markedly increase TB diagnosis over microscopy. The concept of number needed to diagnose can help in comparing incremental yield of diagnosis methods. Although new promising diagnostic molecular methods are being implemented, TB culture is still the gold standard.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization: An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297. 2002, Geneva: WHO World Health Organization: An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297. 2002, Geneva: WHO
2.
go back to reference Enarson DA: International Union Against Tuberculosis and Lung Disease: Management of tuberculosis: a guide for low income countries. 2000, Paris: International Union Against Tuberculosis and Lung Disease, 5 Enarson DA: International Union Against Tuberculosis and Lung Disease: Management of tuberculosis: a guide for low income countries. 2000, Paris: International Union Against Tuberculosis and Lung Disease, 5
3.
go back to reference World Health Organization: Laboratory services in tuberculosis control. Part I: Organization and management. 1998, Geneva: WHO, WHO/TB/98.258 World Health Organization: Laboratory services in tuberculosis control. Part I: Organization and management. 1998, Geneva: WHO, WHO/TB/98.258
4.
go back to reference Pfyffer GE, Palicova F: Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures. Manual of Clinical Microbiology. Edited by: Murray PR, Baron EJ. 2011, American Society for Microbiology. Washington, DC: ASM Press, 472-502. 10 Pfyffer GE, Palicova F: Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures. Manual of Clinical Microbiology. Edited by: Murray PR, Baron EJ. 2011, American Society for Microbiology. Washington, DC: ASM Press, 472-502. 10
5.
go back to reference Lipsky BA, Gates J, Tenover FC, Plorde JJ: Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis. 1984, 6: 214-222. 10.1093/clinids/6.2.214.CrossRefPubMed Lipsky BA, Gates J, Tenover FC, Plorde JJ: Factors affecting the clinical value of microscopy for acid-fast bacilli. Rev Infect Dis. 1984, 6: 214-222. 10.1093/clinids/6.2.214.CrossRefPubMed
6.
go back to reference Van Deun A, Portaels F: Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis. 1998, 2: 756-765.PubMed Van Deun A, Portaels F: Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis. 1998, 2: 756-765.PubMed
7.
go back to reference Van Deun A: What is the role of mycobacterial culture in diagnosis and case finding?. Toman's tuberculosis. Case detection, treatment and monitoring. 2004, Geneva: World Health Organization, 35-43. 2 Van Deun A: What is the role of mycobacterial culture in diagnosis and case finding?. Toman's tuberculosis. Case detection, treatment and monitoring. 2004, Geneva: World Health Organization, 35-43. 2
8.
go back to reference Mase SR, Ramsay A, Ng V, Henry M, Hopewell PC, Cunningham J, et al: Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis. 2007, 11: 485-495.PubMed Mase SR, Ramsay A, Ng V, Henry M, Hopewell PC, Cunningham J, et al: Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis. 2007, 11: 485-495.PubMed
10.
go back to reference Aït-Khaled N, Alarcon E, Armengol R, Bissell K, Boillot F, Caminero JA, et al: Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice. 2010, Paris, France: International Union Against Tuberculosis and Lung Disease Aït-Khaled N, Alarcon E, Armengol R, Bissell K, Boillot F, Caminero JA, et al: Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice. 2010, Paris, France: International Union Against Tuberculosis and Lung Disease
11.
go back to reference Department of Health Western Cape: HIV Prevalence in the Western Cape - Results of the 2006 HIV Antenatal Provincial and Area Surveys. 2007, Cape Town, South Africa: Provincial Government of the Western Cape Department of Health Western Cape: HIV Prevalence in the Western Cape - Results of the 2006 HIV Antenatal Provincial and Area Surveys. 2007, Cape Town, South Africa: Provincial Government of the Western Cape
12.
go back to reference World Health Organization: Global tuberculosis control: WHO report 2011. WHO/HTM/TB/2011. 2011, Geneva: World Health Organization, WHO/HTM/TB/2011.16, 16 World Health Organization: Global tuberculosis control: WHO report 2011. WHO/HTM/TB/2011. 2011, Geneva: World Health Organization, WHO/HTM/TB/2011.16, 16
13.
go back to reference Demers AM, Boulle A, Warren R, Verver S, van Helden P, Behr MA, et al: Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis. Int J Tuberc Lung Dis. 2010, 14: 1016-1023.PubMed Demers AM, Boulle A, Warren R, Verver S, van Helden P, Behr MA, et al: Use of simulated sputum specimens to estimate the specificity of laboratory-diagnosed tuberculosis. Int J Tuberc Lung Dis. 2010, 14: 1016-1023.PubMed
14.
go back to reference South African Department of Health: The South African Tuberculosis Control Programme Practical Guidelines. 2000, South Africa: Pretoria, South Africa, Department of Health, 1–47. 2000 South African Department of Health: The South African Tuberculosis Control Programme Practical Guidelines. 2000, South Africa: Pretoria, South Africa, Department of Health, 1–47. 2000
15.
go back to reference World Health Organization: Laboratory services in tuberculosis control. Part II: Microscopy. 1998, Geneva: WHO, 1-65. WHO/TB/98.258 World Health Organization: Laboratory services in tuberculosis control. Part II: Microscopy. 1998, Geneva: WHO, 1-65. WHO/TB/98.258
16.
go back to reference Van Deun A, Salim AH, Cooreman E, Daru P, Das AP, Aung KJ, et al: Scanty AFB smears: what's in a name?. Int J Tuberc Lung Dis. 2004, 8: 816-823.PubMed Van Deun A, Salim AH, Cooreman E, Daru P, Das AP, Aung KJ, et al: Scanty AFB smears: what's in a name?. Int J Tuberc Lung Dis. 2004, 8: 816-823.PubMed
17.
go back to reference Lawson L, Yassin MA, Ramsay A, Emenyonu NE, Squire SB, Cuevas LE: Comparison of scanty AFB smears against culture in an area with high HIV prevalence. Int J Tuberc Lung Dis. 2005, 9: 933-935.PubMed Lawson L, Yassin MA, Ramsay A, Emenyonu NE, Squire SB, Cuevas LE: Comparison of scanty AFB smears against culture in an area with high HIV prevalence. Int J Tuberc Lung Dis. 2005, 9: 933-935.PubMed
18.
go back to reference World Health Organization: Same-day-diagnosis of tuberculosis by microscopy - Policy Statement. 2011, Geneva: WHO, WHO/HTM/TB/2011.7 World Health Organization: Same-day-diagnosis of tuberculosis by microscopy - Policy Statement. 2011, Geneva: WHO, WHO/HTM/TB/2011.7
19.
go back to reference Rieder HL, Chiang CY, Rusen ID: A method to determine the utility of the third diagnostic and the second follow-up sputum smear examinations to diagnose tuberculosis cases and failures. Int J Tuberc Lung Dis. 2005, 9: 384-391.PubMed Rieder HL, Chiang CY, Rusen ID: A method to determine the utility of the third diagnostic and the second follow-up sputum smear examinations to diagnose tuberculosis cases and failures. Int J Tuberc Lung Dis. 2005, 9: 384-391.PubMed
21.
go back to reference Linn S, Grunau PD: New patient-oriented summary measure of net total gain in certainty for dichotomous diagnostic tests. Epidemiol Perspect Innov. 2006, 3: 11-10.1186/1742-5573-3-11.CrossRefPubMedPubMedCentral Linn S, Grunau PD: New patient-oriented summary measure of net total gain in certainty for dichotomous diagnostic tests. Epidemiol Perspect Innov. 2006, 3: 11-10.1186/1742-5573-3-11.CrossRefPubMedPubMedCentral
22.
go back to reference Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease: Tuberculosis bacteriology-priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis. 2005, 9: 355-361. Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease: Tuberculosis bacteriology-priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis. 2005, 9: 355-361.
23.
go back to reference Urbanczik R: Present position of microscopy and of culture in diagnostic mycobacteriology. Zentralbl Bakteriol Mikrobiol Hyg [A]. 1985, 260: 81-87. Urbanczik R: Present position of microscopy and of culture in diagnostic mycobacteriology. Zentralbl Bakteriol Mikrobiol Hyg [A]. 1985, 260: 81-87.
24.
go back to reference Stop TB, Partnership and World Health Organization: Global Plan to Stop TB 2006–2015. 2006, Geneva: WHO, WHO/HTM/STB/2006.35 Stop TB, Partnership and World Health Organization: Global Plan to Stop TB 2006–2015. 2006, Geneva: WHO, WHO/HTM/STB/2006.35
25.
go back to reference World Health Organization: Improving the diagnosis and treatment of smear-negative pulmonary and extra-pulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. 2007, Geneva: WHO, WHO/HTM/TB/2007.379 World Health Organization: Improving the diagnosis and treatment of smear-negative pulmonary and extra-pulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. 2007, Geneva: WHO, WHO/HTM/TB/2007.379
26.
go back to reference World Health Organization: Treatment of tuberculosis: guidelines. 2009, Geneva: WHO, WHO/HTM/TB/2009.420, 4 World Health Organization: Treatment of tuberculosis: guidelines. 2009, Geneva: WHO, WHO/HTM/TB/2009.420, 4
28.
go back to reference Tuberculosis Coalition for Technical Assistance: International Standards for Tuberculosis Care (ISTC). 2009, The Hague: Tuberculosis Coalition for Technical Assistance, 2 Tuberculosis Coalition for Technical Assistance: International Standards for Tuberculosis Care (ISTC). 2009, The Hague: Tuberculosis Coalition for Technical Assistance, 2
29.
go back to reference Toman K, Frieden T, Toman K, World Health Organization: Toman's tuberculosis. Case detection, treatment, and monitoring: questions and answers. 2004, Geneva: World Health Organization, 2 Toman K, Frieden T, Toman K, World Health Organization: Toman's tuberculosis. Case detection, treatment, and monitoring: questions and answers. 2004, Geneva: World Health Organization, 2
30.
go back to reference Nelson SM, Deike MA, Cartwright CP: Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol. 1998, 36: 467-469.PubMedPubMedCentral Nelson SM, Deike MA, Cartwright CP: Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol. 1998, 36: 467-469.PubMedPubMedCentral
31.
go back to reference Cascina A, Fietta A, Casali L: Is a Large Number of Sputum Specimens Necessary for the Bacteriological Diagnosis of Tuberculosis?. J Clin Microbiol. 2000, 38: 466-PubMedPubMedCentral Cascina A, Fietta A, Casali L: Is a Large Number of Sputum Specimens Necessary for the Bacteriological Diagnosis of Tuberculosis?. J Clin Microbiol. 2000, 38: 466-PubMedPubMedCentral
32.
go back to reference Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Nguyen HD, Nguyen TN, et al: Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med. 2009, 180: 903-908. 10.1164/rccm.200905-0692OC.CrossRefPubMed Monkongdee P, McCarthy KD, Cain KP, Tasaneeyapan T, Nguyen HD, Nguyen TN, et al: Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med. 2009, 180: 903-908. 10.1164/rccm.200905-0692OC.CrossRefPubMed
33.
go back to reference Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C: Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of Mycobacteria. J Clin Microbiol. 2004, 42: 2321-2325. 10.1128/JCM.42.5.2321-2325.2004.CrossRefPubMedPubMedCentral Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, Mengoli C: Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of Mycobacteria. J Clin Microbiol. 2004, 42: 2321-2325. 10.1128/JCM.42.5.2321-2325.2004.CrossRefPubMedPubMedCentral
34.
go back to reference Chihota VN, Grant AD, Fielding K, Ndibongo B, van Zyl A, Muirhead D, et al: Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int J Tuberc Lung Dis. 2010, 14: 1024-1031.PubMed Chihota VN, Grant AD, Fielding K, Ndibongo B, van Zyl A, Muirhead D, et al: Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int J Tuberc Lung Dis. 2010, 14: 1024-1031.PubMed
35.
go back to reference Ssengooba W, Kiwanuka N, Kateete DP, Katamba A, Joloba ML: Incremental Yield of Serial Sputum Cultures for Diagnosis of Tuberculosis among HIV Infected Smear Negative Pulmonary TB Suspects in Kampala, Uganda. PLoS One. 2012, 7: e37650-10.1371/journal.pone.0037650.CrossRefPubMedPubMedCentral Ssengooba W, Kiwanuka N, Kateete DP, Katamba A, Joloba ML: Incremental Yield of Serial Sputum Cultures for Diagnosis of Tuberculosis among HIV Infected Smear Negative Pulmonary TB Suspects in Kampala, Uganda. PLoS One. 2012, 7: e37650-10.1371/journal.pone.0037650.CrossRefPubMedPubMedCentral
36.
go back to reference Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al: Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010, 363: 1005-1015. 10.1056/NEJMoa0907847.CrossRefPubMedPubMedCentral Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al: Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010, 363: 1005-1015. 10.1056/NEJMoa0907847.CrossRefPubMedPubMedCentral
37.
go back to reference World Health Organization: Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. 2011, Geneva: World Health Organization, WHO/HTM/TB/2011.4 World Health Organization: Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. 2011, Geneva: World Health Organization, WHO/HTM/TB/2011.4
38.
go back to reference Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al: Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011, 8: e1001067-10.1371/journal.pmed.1001067.CrossRefPubMedPubMedCentral Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, et al: Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med. 2011, 8: e1001067-10.1371/journal.pmed.1001067.CrossRefPubMedPubMedCentral
39.
go back to reference Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, et al: Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. 2011, 184: 132-140. 10.1164/rccm.201101-0056OC.CrossRefPubMed Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, et al: Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. 2011, 184: 132-140. 10.1164/rccm.201101-0056OC.CrossRefPubMed
40.
go back to reference Vassall A, van Kampen S, Sohn H, Michael JS, John KR, DEN BS, et al: Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med. 2011, 8: e1001120-10.1371/journal.pmed.1001120.CrossRefPubMedPubMedCentral Vassall A, van Kampen S, Sohn H, Michael JS, John KR, DEN BS, et al: Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med. 2011, 8: e1001120-10.1371/journal.pmed.1001120.CrossRefPubMedPubMedCentral
Metadata
Title
High yield of culture-based diagnosis in a TB-endemic setting
Authors
Anne-Marie Demers
Suzanne Verver
Andrew Boulle
Robin Warren
Paul van Helden
Marcel A Behr
David Coetzee
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-218

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.